Opioid use disorder and COVID-19: Implications for policy and practice

被引：6

作者：

Mitchell, Michaela ^{[1
]}

Shee, Kameron ^{[1
]}

Champlin, Kelly ^{[2
]}

Essary, Alison C. ^{[3
,4
]}

Evans, Matthew ^{[5
]}

机构：

[1] HonorHlth Acad Affairs, Scottsdale, AZ USA

[2] Midwestern Univ, Arizona Coll Osteopath Med, Downers Grove, IL 60515 USA

[3] HonorHlth Acad Affairs, Res Qual Improvement & Patient Safety program, Scottsdale, AZ USA

[4] No Arizona Univ, Coll Hlth Sci, Biomed Campus, Flagstaff, AZ 86011 USA

[5] HonorHlth Community Bridges Inc, Scottsdale, AZ USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2021年 / 34卷 / 06期

关键词：

opioid use disorder; COVID-19; medications for addiction treatment; telehealth; regulatory; policy; DISPARITIES;

D O I：

10.1097/01.JAA.0000742976.14811.36

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Preliminary data suggest that opioid-related overdose deaths have increased subsequent to COVID-19. Despite national support for expanding the role of physician assistants (PAs) and NPs in serving patients with opioid use disorder, these clinicians are held to complex and stringent regulatory barriers. COVID-19 triggered significant changes from regulatory and federal agencies, yet disparate policies and regulations persist between physicians and PAs and NPs. The dual epidemics of COVID-19 and opioid use disorder highlight the inadequate infrastructure required to support patients, communities, and clinicians, and may serve as the catalyst for eliminating barriers to care.

引用

页码：1 / 4

页数：4

共 29 条

[1]

Alter A., CONSEQUENCES COVID 1

[2]

American Society of Addiction Medicine, SUBST US DIS PREV PR

[3] In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants [J].